No. 3 Publication of Exemption Document and NewCo BoD Composition
Kurs & Likviditet
Kalender
| 2025-02-06 | Bokslutskommuniké 2024 |
| 2024-11-06 | Kvartalsrapport 2024-Q3 |
| 2024-08-15 | Kvartalsrapport 2024-Q2 |
| 2024-05-07 | Kvartalsrapport 2024-Q1 |
| 2023-11-22 | Årsstämma 2024 |
| 2023-10-13 | Bonusutdelning CHR 7.72 |
| 2023-10-12 | Bokslutskommuniké 2023 |
| 2023-07-06 | Kvartalsrapport 2023-Q3 |
| 2023-04-13 | Kvartalsrapport 2023-Q2 |
| 2023-03-30 | Extra Bolagsstämma 2023 |
| 2023-01-12 | Kvartalsrapport 2023-Q1 |
| 2022-11-24 | Ordinarie utdelning CHR 7.04 DKK |
| 2022-11-23 | Årsstämma 2023 |
| 2022-10-12 | Bokslutskommuniké 2022 |
| 2022-07-07 | Kvartalsrapport 2022-Q3 |
| 2022-04-06 | Kvartalsrapport 2022-Q2 |
| 2022-01-13 | Kvartalsrapport 2022-Q1 |
| 2021-11-25 | Ordinarie utdelning CHR 6.54 DKK |
| 2021-11-24 | Årsstämma 2022 |
| 2021-10-14 | Bokslutskommuniké 2021 |
| 2021-07-08 | Kvartalsrapport 2021-Q3 |
| 2021-05-18 | Bonusutdelning CHR 6.54 |
| 2021-04-15 | Kvartalsrapport 2021-Q2 |
| 2021-01-14 | Kvartalsrapport 2021-Q1 |
| 2020-11-26 | Ordinarie utdelning CHR 0.00 DKK |
| 2020-11-25 | Årsstämma 2021 |
| 2020-10-08 | Bokslutskommuniké 2020 |
| 2020-07-02 | Kvartalsrapport 2020-Q3 |
| 2020-04-16 | Kvartalsrapport 2020-Q2 |
| 2020-01-15 | Kvartalsrapport 2020-Q1 |
| 2019-11-28 | Ordinarie utdelning CHR 7.07 DKK |
| 2019-11-27 | Årsstämma 2020 |
| 2019-10-10 | Bokslutskommuniké 2019 |
| 2019-07-03 | Kvartalsrapport 2019-Q3 |
| 2019-04-03 | Kvartalsrapport 2019-Q2 |
| 2019-01-17 | Kvartalsrapport 2019-Q1 |
| 2018-11-30 | Ordinarie utdelning CHR 6.47 DKK |
| 2018-11-29 | Årsstämma 2019 |
| 2018-10-15 | Bokslutskommuniké 2018 |
| 2018-06-29 | Bonusutdelning CHR 5.94 |
| 2018-06-28 | Kvartalsrapport 2018-Q3 |
| 2018-04-11 | Kvartalsrapport 2018-Q2 |
| 2018-01-12 | Kvartalsrapport 2018-Q1 |
| 2017-11-29 | Ordinarie utdelning CHR 6.33 DKK |
| 2017-11-29 | Årsstämma 2018 |
| 2017-11-28 | Årsstämma 2018 |
| 2017-10-25 | Bokslutskommuniké 2017 |
| 2017-07-11 | Bonusutdelning CHR 5.64 |
| 2017-07-05 | Kvartalsrapport 2017-Q3 |
| 2017-04-06 | Kvartalsrapport 2017-Q2 |
| 2017-01-11 | Kvartalsrapport 2017-Q1 |
| 2016-11-30 | Ordinarie utdelning CHR 5.23 DKK |
| 2016-11-29 | Årsstämma 2017 |
| 2016-10-26 | Bokslutskommuniké 2016 |
| 2016-07-05 | Kvartalsrapport 2016-Q3 |
| 2016-04-07 | Kvartalsrapport 2016-Q2 |
| 2016-01-14 | Kvartalsrapport 2016-Q1 |
| 2015-11-27 | Ordinarie utdelning CHR 4.70 DKK |
| 2015-11-26 | Årsstämma 2016 |
| 2015-10-21 | Bokslutskommuniké 2015 |
| 2015-07-07 | Bonusutdelning CHR 6.57 |
| 2015-07-01 | Kvartalsrapport 2015-Q3 |
| 2015-04-09 | Kvartalsrapport 2015-Q2 |
| 2015-01-21 | Kvartalsrapport 2015-Q1 |
| 2014-11-28 | Ordinarie utdelning CHR 3.77 DKK |
| 2014-11-27 | Årsstämma 2015 |
| 2014-10-22 | Bokslutskommuniké 2014 |
| 2014-07-02 | Kvartalsrapport 2014-Q3 |
| 2014-04-09 | Kvartalsrapport 2014-Q2 |
| 2014-01-15 | Kvartalsrapport 2014-Q1 |
| 2013-11-27 | Bonusutdelning CHR 3.13 |
| 2013-11-27 | Ordinarie utdelning CHR 3.13 DKK |
| 2013-11-26 | Årsstämma 2014 |
| 2013-10-23 | Bokslutskommuniké 2013 |
| 2013-07-03 | Kvartalsrapport 2013-Q3 |
| 2013-04-11 | Kvartalsrapport 2013-Q2 |
| 2013-01-16 | Kvartalsrapport 2013-Q1 |
| 2012-11-28 | Ordinarie utdelning CHR 2.90 DKK |
| 2012-11-27 | Årsstämma 2013 |
| 2012-07-04 | Kvartalsrapport 2012-Q3 |
| 2012-04-19 | Kvartalsrapport 2012-Q2 |
| 2012-01-11 | Kvartalsrapport 2012-Q1 |
| 2011-11-30 | Ordinarie utdelning CHR 3.57 DKK |
| 2011-11-29 | Årsstämma 2012 |
| 2011-07-06 | Kvartalsrapport 2011-Q3 |
| 2011-04-06 | Kvartalsrapport 2011-Q2 |
| 2011-01-12 | Kvartalsrapport 2011-Q1 |
| 2010-12-01 | Ordinarie utdelning CHR 0.64 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Bioteknik |
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL.
March 8, 2023 – Company announcement no. 3 |
On December 12, 2022, Novozymes A/S ("Novozymes") and Chr. Hansen Holding A/S ("Chr. Hansen") announced that Novozymes and Chr. Hansen had entered into a merger agreement to combine by way of a statutory merger of the two companies (the "Combination") and thereby create a leading global biosolutions partner, with Novozymes as the continuing company for which Novozymes and Chr. Hansen jointly will develop a new name and brand (the "Combined Company"). Reference is made to Chr. Hansen's company announcement no. 13 of December 12, 2022.
Novozymes and Chr. Hansen will today through separate company announcements publish notices to convene their respective extraordinary general meetings to vote on the Combination.
As stated in Chr. Hansen's company announcement no. 13, 2022, each of the Novozymes Board of Directors and the Chr. Hansen Board of Directors support the Combination and unanimously recommend their respective shareholders to vote in favor of and adopt the Combination and the other proposals to be put forward by the Novozymes Board of Directors and the Chr. Hansen Board of Directors, respectively, in relation to the Combination.
Please see attachment.
CONTACT INFORMATION
Investor Relations
Anders Mohr Christensen
+45 2515 2364
dkamc@chr-hansen.com
Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com